The gene activity of "designer" human cells can be remotely toggled on and off with electric currents, a new study in mice shows.
In a study published July 31 in the journal Nature Metabolism, direct current (DC) from off-the-shelf consumer batteries triggered the release of insulin from genetically engineered human cells that scientists had implanted under the skin of diabetic mice. The insulin successfully restored the rodents' normal blood sugar levels.
